Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IRB Approval Seen As Minimum Bar For Medicare Clinical Trial Coverage

This article was originally published in The Gray Sheet

Executive Summary

An multi-agency panel convened by the Agency for Healthcare Research and Quality is considering whether IRB approval alone is sufficient proof that a clinical trial merits Medicare coverage.

You may also be interested in...



HCFA Medicare Clinical Trials Coverage Criteria Near Completion

HCFA expects to issue self-certification criteria within the next month for clinical trials seeking Medicare coverage of routine care costs, HCFA Division of Items & Devices Director John Whyte, MD, announced at a Feb. 6 FDLI-sponsored conference held in Washington, D.C.

HCFA Medicare Clinical Trials Coverage Criteria Near Completion

HCFA expects to issue self-certification criteria within the next month for clinical trials seeking Medicare coverage of routine care costs, HCFA Division of Items & Devices Director John Whyte, MD, announced at a Feb. 6 FDLI-sponsored conference held in Washington, D.C.

AHRQ Panel Urged To Support Medicare Coverage Of IDE Clinical Trials

Clinical trials approved by FDA under investigational device exemptions should be able to self-certify for Medicare coverage, AdvaMed recommended Nov. 20 before a multi-agency panel convened by the Agency for Healthcare Research and Quality.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014046

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel